What to Do About Histiocytic Necrotizing Lymphadenitis

When a patient presents with persistent fever, tender cervical lymphadenopathy, and systemic symptoms such as fatigue or night sweats—particularly in young adults—the diagnosis of histiocytic necrotizing lymphadenitis (also known as Kikuchi-Fujimoto disease) should be considered. This rare, self-limiting condition predominantly affects women under 40 and is characterized by benign, localized inflammation and apoptosis-driven necrosis within lymph nodes, most commonly in the neck.

Diagnosis relies on excisional lymph node biopsy, as fine-needle aspiration is insufficient to capture the characteristic histopathologic features: paracortical expansion with karyorrhectic debris, abundant histiocytes, and absence of neutrophils or granulomas. Immunohistochemistry typically shows CD68-positive histiocytes and CD3/CD8-positive T lymphocytes, with no evidence of malignancy or infectious organisms on special stains or PCR testing.

Management is primarily supportive. Most patients experience spontaneous resolution within one to four months without specific therapy. Symptomatic treatment—including acetaminophen or NSAIDs for fever and pain—is appropriate. Corticosteroids are not routinely recommended, as they do not alter disease course and may mask underlying conditions; however, they may be considered in rare cases with severe constitutional symptoms or atypical, prolonged presentations.

Although recurrence occurs in approximately 3–5% of cases, long-term prognosis is excellent. Importantly, clinicians must exclude mimics—including systemic lupus erythematosus (SLE), lymphoma, and viral infections such as EBV or HIV—through comprehensive serologic evaluation, imaging, and histopathologic correlation before confirming the diagnosis.